This drug was previously shown to restore the endothelial surface layer [ 52 ] and to lower blood pressure with borderline significant effects on plasma sodium [ 53 ].
← all excerpts
Distinct osmoregulatory responses to sodium loading in patients with altered glycosaminoglycan structure: a randomized cross-over trial.
1
—
—